Alector (ALEC) EBT Growth (3y) (2021 - 2026)
Powered by 
Analysis
Alector (ALEC) EBT Growth (3y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 19.70% |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | -103.74% |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 6.22% |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 12.16% |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | 103.79% |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | 24.03% |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 38.36% |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | -42.82% |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | 64.03% |
| 10 | Alector | 274.68 Mn | 101.88 Mn | - | -117.29% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -117.29% |
| Mar 31, 2026 | 20.10% |
| Dec 31, 2025 | 10.48% |
| Sep 30, 2025 | 8.61% |
| Jun 30, 2025 | -68.62% |
| Mar 31, 2025 | 2.64% |
| Dec 31, 2024 | 66.85% |
| Sep 30, 2024 | -32.64% |
| Jun 30, 2024 | 11.21% |
| Mar 31, 2024 | 11.57% |
| Dec 31, 2023 | 8.99% |
| Sep 30, 2023 | 7.01% |
| Jun 30, 2023 | 27.23% |
| Mar 31, 2023 | -2.23% |
| Dec 31, 2022 | -16.93% |
| Sep 30, 2022 | -9.97% |
| Jun 30, 2022 | 33.93% |
| Mar 31, 2022 | -28.31% |
| Dec 31, 2021 | -43.00% |
| Sep 30, 2021 | 112.01% |